Federated Hermes, Inc. Becton Dickinson & CO Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Federated Hermes, Inc. holds 17,087 shares of BDX stock, worth $3.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,087

Previous 15,945 7.16%

Holding current value

$3.88 Million

Previous $3.73 Million 10.55%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$221.47 - $242.41 $252,918 - $276,832	1,142 Added 7.16%	17,087 $4.12 Million
Q2 2024 Aug 08, 2024	SELL	$225.07 - $246.17 $114,560 - $125,300	-509 Reduced 3.09%	15,945 $3.73 Million
Q1 2024 May 14, 2024	SELL	$233.45 - $247.73 $150,808 - $160,033	-646 Reduced 3.78%	16,454 $4.07 Million
Q4 2023 Jan 31, 2024	SELL	$232.24 - $267.23 $234,562 - $269,902	-1,010 Reduced 5.58%	17,100 $4.17 Million
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $403,251 - $448,639	-1,582 Reduced 8.03%	18,110 $4.68 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $2.75 Million - $3.06 Million	11,551 Added 141.89%	19,692 $5.2 Million
Q1 2023 May 08, 2023	SELL	$229.71 - $259.35 $18,606 - $21,007	-81 Reduced 0.99%	8,141 $2.02 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $19,209 - $22,608	88 Added 1.08%	8,222 $2.09 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $561 - $2,906	-11 Reduced 0.14%	8,134 $1.81 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $1.81 Million - $2.12 Million	-7,693 Reduced 48.57%	8,145 $2.01 Million
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $598,136 - $664,028	-2,455 Reduced 13.42%	15,838 $4.21 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $289,210 - $315,431	1,257 Added 7.38%	18,293 $4.6 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $45,613 - $50,268	-196 Reduced 1.14%	17,036 $4.19 Million
Q2 2021 Aug 16, 2021	BUY	$232.65 - $254.58 $608,147 - $665,472	2,614 Added 17.88%	17,232 $4.19 Million
Q1 2021 May 13, 2021	BUY	$232.09 - $256.88 $1.19 Million - $1.32 Million	5,136 Added 54.17%	14,618 $3.55 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $48,156 - $53,368	-217 Reduced 2.24%	9,482 $2.37 Million
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $118,241 - $151,664	-548 Reduced 5.35%	9,699 $2.26 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $5.92 Million - $7.09 Million	-26,900 Reduced 72.41%	10,247 $2.45 Million
Q1 2020 May 13, 2020	BUY	$195.69 - $279.01 $12,524 - $17,856	64 Added 0.17%	37,147 $8.54 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $713,842 - $805,529	-3,019 Reduced 7.53%	37,083 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $6.82 Million - $7.57 Million	29,567 Added 280.65%	40,102 $10.1 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $9.79 Million - $11.1 Million	-45,015 Reduced 81.04%	10,535 $2.66 Million
Q1 2019 May 10, 2019	BUY	$206.05 - $248.17 $10.7 Million - $12.9 Million	51,965 Added 1449.51%	55,550 $13.9 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $196,336 - $247,354	-959 Reduced 21.1%	3,585 $788,000
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $84,371 - $92,672	-362 Reduced 7.38%	4,544 $1.19 Million
Q2 2018 Aug 10, 2018	SELL	$208.1 - $233.85 $70,545 - $79,275	-339 Reduced 6.46%	4,906 $1.18 Million
Q1 2018 May 09, 2018	SELL	$205.46 - $240.27 $101,291 - $118,453	-493 Reduced 8.59%	5,245 $1.14 Million
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $3.01 Million - $3.55 Million	-15,940 Reduced 73.53%	5,738 $0
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $4.05 Million - $4.31 Million	21,678	21,678 $4.25 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Becton Dickinson & CO Transaction History